Clinical Trial Update: Gabapentin Reduces Opioid Use Postoperatively ("GROUP Study") [Phase 3]

View source ↗

Summary

Phase 3 trial (GROUP Study) evaluating gabapentin to reduce postoperative opioid use in pelvic organ prolapse; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pelvic Organ Prolapse

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: Mount Sinai Hospital, Canada | Conditions: Pelvic Organ Prolapse | Phase 3 | Status: UNKNOWN